InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Anika Therapeutics, Inc.

ANIK Clue Score53
United States Fiscal year ends December CIK 0000898437
$19.58 +1.82% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $19.58 −51.79% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue103.4Operating income50.6Net income32.5EPS, diluted2.15Fiscal year 2017Revenue113.4 +9.7%Operating income45.7Net income31.8 −2.2%EPS, diluted2.11 −1.9%Fiscal year 2018Revenue105.6 −6.9%Operating income21.7Net income18.7 −41.2%EPS, diluted1.27 −39.8%Fiscal year 2019Revenue114.6 +8.6%Operating income34.2Net income27.2 +45.2%EPS, diluted1.89 +48.8%Fiscal year 2020Revenue130.5 +13.8%Operating income−28.3Net income−24.0 −188.2%EPS, diluted−1.69 −189.4%Fiscal year 2021Revenue147.8 +13.3%Operating income2.6Net income4.1EPS, diluted0.28Fiscal year 2022Revenue113.8 −23.0%Operating income3.7Net income−14.9 −459.4%EPS, diluted−1.02 −464.3%Fiscal year 2023Revenue120.8 +6.1%Operating income0.8Net income−82.7EPS, diluted−5.64Fiscal year 2024Revenue119.9 −0.7%Operating income−5.1Net income−56.4EPS, diluted−3.83Fiscal year 2025Revenue112.8 −5.9%Operating income−11.1Net income−10.9EPS, diluted−0.76
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 103.4 113.4 105.6 114.6 130.5 147.8 113.8 120.8 119.9 112.8
Growth +9.7% −6.9% +8.6% +13.8% +13.3% −23.0% +6.1% −0.7% −5.9%
Operating income 50.6 45.7 21.7 34.2 −28.3 2.6 3.7 0.8 −5.1 −11.1
Net income 32.5 31.8 18.7 27.2 −24.0 4.1 −14.9 −82.7 −56.4 −10.9
Growth −2.2% −41.2% +45.2% −188.2% −459.4%
EPS, diluted 2.15 2.11 1.27 1.89 −1.69 0.28 −1.02 −5.64 −3.83 −0.76
Growth −1.9% −39.8% +48.8% −189.4% −464.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin49.0%Net margin31.5%Free cash flow margin10.1%Fiscal year 2017Operating margin40.3%Net margin28.1%Free cash flow margin28.1%Fiscal year 2018Gross margin70.4%Operating margin20.6%Net margin17.7%Free cash flow margin28.7%Fiscal year 2019Gross margin74.9%Operating margin29.9%Net margin23.7%Free cash flow margin29.8%Fiscal year 2020Gross margin52.9%Operating margin−21.7%Net margin−18.4%Free cash flow margin8.8%Fiscal year 2021Gross margin56.1%Operating margin1.8%Net margin2.8%Free cash flow margin2.2%Fiscal year 2022Gross margin64.3%Operating margin3.2%Net margin−13.1%Free cash flow margin−2.7%Fiscal year 2023Gross margin68.3%Operating margin0.7%Net margin−68.4%Free cash flow margin−6.0%Fiscal year 2024Gross margin63.4%Operating margin−4.3%Net margin−47.0%Free cash flow margin−1.9%Fiscal year 2025Gross margin56.6%Operating margin−9.8%Net margin−9.6%Free cash flow margin3.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a 70.4% 74.9% 52.9% 56.1% 64.3% 68.3% 63.4% 56.6%
Operating margin 49.0% 40.3% 20.6% 29.9% −21.7% 1.8% 3.2% 0.7% −4.3% −9.8%
Net margin 31.5% 28.1% 17.7% 23.7% −18.4% 2.8% −13.1% −68.4% −47.0% −9.6%
Free cash flow margin 10.1% 28.1% 28.7% 29.8% 8.8% 2.2% −2.7% −6.0% −1.9% 3.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow24.4Capital expenditure−14.0Free cash flow10.4Buybacks−25.0Fiscal year 2017Operating cash flow40.8Capital expenditure−9.0Free cash flow31.8 +205.1%Fiscal year 2018Operating cash flow34.9Capital expenditure−4.7Free cash flow30.3 −4.9%Buybacks−30.0Fiscal year 2019Operating cash flow37.0Capital expenditure−2.8Free cash flow34.2 +12.9%Buybacks−30.0Fiscal year 2020Operating cash flow13.1Capital expenditure−1.6Free cash flow11.4 −66.5%Buybacks0.0Fiscal year 2021Operating cash flow8.4Capital expenditure−5.1Free cash flow3.3 −71.5%Buybacks0.0Fiscal year 2022Operating cash flow4.4Capital expenditure−7.5Free cash flow−3.1 −194.6%Buybacks0.0Fiscal year 2023Operating cash flow−1.8Capital expenditure−5.4Free cash flow−7.2Buybacks−5.0Fiscal year 2024Operating cash flow5.4Capital expenditure−7.7Free cash flow−2.3Buybacks−10.9Fiscal year 2025Operating cash flow11.2Capital expenditure−6.8Free cash flow4.4Buybacks−9.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 24.4 40.8 34.9 37.0 13.1 8.4 4.4 −1.8 5.4 11.2
Capital expenditure −14.0 −9.0 −4.7 −2.8 −1.6 −5.1 −7.5 −5.4 −7.7 −6.8
Free cash flow 10.4 31.8 30.3 34.2 11.4 3.3 −3.1 −7.2 −2.3 4.4
Growth +205.1% −4.9% +12.9% −66.5% −71.5% −194.6%
Buybacks −25.0 n/a −30.0 −30.0 0.0 0.0 0.0 −5.0 −10.9 −9.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash104.3Shareholders’ equity222.8Fiscal year 2017Cash133.3Shareholders’ equity263.5Fiscal year 2018Cash89.0Shareholders’ equity263.6Fiscal year 2019Cash157.5Total debt0.0Net cash (debt)157.5Shareholders’ equity288.4Debt to equity0.00Fiscal year 2020Cash95.8Shareholders’ equity272.4Fiscal year 2021Cash94.4Shareholders’ equity287.1Fiscal year 2022Cash86.3Shareholders’ equity285.6Fiscal year 2023Cash68.7Shareholders’ equity212.3Fiscal year 2024Cash55.6Shareholders’ equity154.0Fiscal year 2025Cash57.5Shareholders’ equity143.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 104.3 133.3 89.0 157.5 95.8 94.4 86.3 68.7 55.6 57.5
Total debt n/a n/a n/a 0.0 n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a 157.5 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 222.8 263.5 263.6 288.4 272.4 287.1 285.6 212.3 154.0 143.5
Debt to equity n/a n/a n/a 0.00 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
103.4 113.4 105.6 114.6 130.5 147.8 113.8 120.8 119.9 112.8
Growth +9.7% −6.9% +8.6% +13.8% +13.3% −23.0% +6.1% −0.7% −5.9%
24.0 27.4 31.3 28.7 61.4 64.9 40.6 38.3 43.9 49.0
n/a n/a 74.3 85.9 69.0 82.9 73.2 82.5 76.0 63.8
Growth +15.6% −19.6% +20.2% −11.7% +12.7% −7.9% −16.0%
10.7 18.8 18.2 16.7 23.4 27.3 18.3 21.8 25.5 25.8
18.0 21.5 34.3 35.0 60.1 74.1 51.2 59.9 55.6 49.1
50.6 45.7 21.7 34.2 −28.3 2.6 3.7 0.8 −5.1 −11.1
Growth −9.6% −52.4% +57.5% −182.7% +40.3% −77.0% −704.4%
50.9 46.2 23.2 36.1 −28.6 2.4 4.3 3.2 −2.8 −9.3
18.3 14.4 4.5 8.9 −4.6 −1.7 2.1 6.6 6.1 0.7
32.5 31.8 18.7 27.2 −24.0 4.1 −14.9 −82.7 −56.4 −10.9
Growth −2.2% −41.2% +45.2% −188.2% −459.4%
Per share
2.22 2.18 1.30 1.93 −1.69 0.29 −1.02 −5.64 −3.83 −0.76
2.15 2.11 1.27 1.89 −1.69 0.28 −1.02 −5.64 −3.83 −0.76
Growth −1.9% −39.8% +48.8% −189.4% −464.3%
14.7 14.6 14.4 14.1 14.2 14.4 14.6 14.7 14.7 14.3
15.1 15.1 14.7 14.4 14.2 14.6 14.8 14.7 14.7 14.3
Growth −0.3% −2.5% −2.1% −1.1% +2.9% +1.0% −0.9% +0.4% −2.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 2.9% a year over five years.
  • The share count barely moved in five years.
  • Operating margin is up 11.9 points on five years ago, at -9.8%.
  • A net loss in 5 of 10 years on file.